An Updated Review of SARS-CoV-2 Vaccines and the Importance of Effective Vaccination Programs in Pandemic Times.

An Updated Review of SARS-CoV-2 Vaccines and the Importance of Effective Vaccination Programs in Pandemic Times.
复制标题

DOI:
10.3390/vaccines9050433
复制
发表时间:
2021-04-27
期刊:
影响因子:
7.8
通讯作者:
Ortega MA
Ortega MA
中科院分区:
医学3区
文献类型:
--
作者:
García-Montero C;Fraile-Martínez O;Bravo C;Torres-Carranza D;Sanchez-Trujillo L;Gómez-Lahoz AM;Guijarro LG;García-Honduvilla N;Asúnsolo A;Bujan J;Monserrat J;Serrano E;Álvarez-Mon M;De León-Luis JA;Álvarez-Mon MA;Ortega MA

文献摘要

参考文献

被引文献

相似文献

自从一年前宣布全球爆发新冠肺炎疫情以来,在全球250万人死亡、卫生系统超载和巨大经济负担之后,寻找疫苗已成为恢复正常的首要任务。疫苗的开发代表着在短时间内朝着理想的群体免疫迈出的一步,这是由于高水平的投资、研究人员的重点以及对授权更快地接种疫苗的敦促。然而,只有在世界各国推行有效的战略和政策,才能实现这一目标。在本综述中,除了在公众不愿意、阴谋论或缺乏信息的情况下在大流行中接种疫苗的重要性外,还讨论了实现成功的疫苗接种计划所涉及的一些方面。此外,我们提供了一些与候选疫苗临床开发前景相关的最新要点,特别是已经在第四阶段临床试验中评估的前五种疫苗(BNT162b2、mRNA-1273、AZD1222、Ad26.COV2.S和CoronaVac)。
Since the worldwide COVID-19 pandemic was declared a year ago, the search for vaccines has become the top priority in order to restore normalcy after 2.5 million deaths worldwide, overloaded sanitary systems, and a huge economic burden. Vaccine development has represented a step towards the desired herd immunity in a short period of time, owing to a high level of investment, the focus of researchers, and the urge for the authorization of the faster administration of vaccines. Nevertheless, this objective may only be achieved by pursuing effective strategies and policies in various countries worldwide. In the present review, some aspects involved in accomplishing a successful vaccination program are addressed, in addition to the importance of vaccination in a pandemic in the face of unwillingness, conspiracy theories, or a lack of information among the public. Moreover, we provide some updated points related to the landscape of the clinical development of vaccine candidates, specifically, the top five vaccines that are already being assessed in Phase IV clinical trials (BNT162b2, mRNA-1273, AZD1222, Ad26.COV2.S, and CoronaVac).
DOI: 10.1016/j.med.2020.12.011
发表时间: 2020-12
期刊: Medicine
影响因子: 1.6
作者:
Barco AAD;Ortega MA
通讯作者: Ortega MA
DOI: 10.3390/vaccines9010065
发表时间: 2021-01-19
期刊: Vaccines
影响因子: 7.8
作者:
Buschmann MD;Carrasco MJ;Alishetty S;Paige M;Alameh MG;Weissman D
通讯作者: Weissman D
DOI: 10.3390/jpm11010036
发表时间: 2021-01-08
影响因子: --
作者:
Álvarez-Mon M;Ortega MA;Gasulla Ó;Fortuny-Profitós J;Mazaira-Font FA;Saurina P;Monserrat J;Plana MN;Troncoso D;Moreno JS;Muñoz B;Arranz A;Varona JF;Lopez-Escobar A;Barco AA
通讯作者: Barco AA
DOI: 10.3389/fimmu.2020.569760
发表时间: 2020
影响因子: 7.3
作者:
Canedo-Marroquín G;Saavedra F;Andrade CA;Berrios RV;Rodríguez-Guilarte L;Opazo MC;Riedel CA;Kalergis AM
通讯作者: Kalergis AM
优化 SARS-CoV-2 接种中的疫苗剂量,一项旨在最大限度提高疫苗安全性和功效的多因素优化建模研究。
DOI: 10.3390/vaccines9020078
发表时间: 2021-01-22
期刊: Vaccines
影响因子: 7.8
作者:
Benest J;Rhodes S;Quaife M;Evans TG;White RG
通讯作者: White RG